Skip to main content
Addgene

Co-targeting CK2alpha and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.

Xu WF, Ma YC, Ma HS, Shi L, Mu H, Ou WB, Peng J, Li TT, Qin T, Zhou HM, Fu XQ, Li XH
Cell Cycle. 2019 Dec;18(24):3472-3490. doi: 10.1080/15384101.2019.1689474. Epub 2019 Nov 12. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article